Pholcodine-containing cough medicines: benefit / risk balance still positive

Following the suspicion of cross-sensitization between pholcodine and neuromuscular blocking agents used in surgery, which could be the cause of the occurrence of anaphylactic reactions, the Committee for Medicinal Products for Human Use of the European Medicines Agency has reviewed all the data on safety and efficiency of available pholcodine-containing medicines and advises that their benefit / risk balance remains positive.

See EMA website.


Contact: vig@fagg-afmps.be  

Last updated on
30/11/2011